Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Trial details
- Registry ID
- NCT06577090
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs PlaceboNCT06577090 | SKYE | Phase 2 | Active not recruiting | 2026-11-20Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |